[VRTX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
10-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -11.99%
YoY- 6.34%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 2,483,500 2,493,200 2,374,800 2,302,700 2,334,300 2,196,200 2,097,500 11.90%
PBT 1,179,200 1,161,500 891,500 1,076,800 1,176,400 1,024,400 954,800 15.09%
Tax 143,900 245,800 191,700 257,900 245,900 213,900 192,700 -17.67%
NP 1,035,300 915,700 699,800 818,900 930,500 810,500 762,100 22.63%
Tax Rate -12.20% -21.16% -21.50% -23.95% -20.90% -20.88% -20.18% -
Total Cost 1,448,200 1,577,500 1,675,000 1,483,800 1,403,800 1,385,700 1,335,400 5.54%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 41.69 36.73 29.47 35.56 39.86 36.90 36.33 9.59%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS 4.01 3.55 2.72 3.19 3.63 3.17 2.99 21.59%
EPS Diluted 3.97 3.52 2.69 3.15 3.59 3.13 2.96 21.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.